MethodHub Software Limited has scheduled its Tenth Annual General Meeting (AGM) for Tuesday, September 29, 2026. The meeting will be held at 2:30 pm IST through Video Conferencing or Other Audio-Visual Means, in compliance with Ministry of Corporate Affairs circulars.

The Board of Directors approved the agenda during a meeting held on Thursday, August 20, 2026. The session commenced at 3:03 pm and concluded at 4:30 pm IST.

Key Dates and Details

Shareholders on record as of September 22, 2026 will be eligible to cast their votes. This cut-off date was fixed in accordance with Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014.

The company will dispatch the AGM notice to shareholders via registered email addresses. The notice will also be intimated to stock exchanges as per applicable laws. The meeting pertains to the financial year ended March 31, 2026.

MethodHub Software Limited has partnered with Datafoundry to strengthen its AI-driven Pharmacovigilance (PV) and pharma-tech offerings for global pharmaceutical, biotech, and life sciences enterprises. The strategic collaboration, announced on July 06, 2026, aims to deliver end-to-end, technology-led solutions that address increasing regulatory scrutiny and the growing complexity of global clinical data. By combining MethodHub's operational capabilities with Datafoundry's advanced AI platforms, the partnership seeks to transition organizations from fragmented, manual PV processes to intelligent, automated, and scalable safety operations.

Under the agreement, MethodHub will leverage its expertise in PV operations, regulatory compliance, and global delivery, while Datafoundry will contribute its purpose-built AI/ML SaaS solutions. The integration is designed to streamline workflows, improve accuracy, and enhance regulatory compliance aligned with global standards such as FDA and EMA guidelines.

Datafoundry's suite of AI-powered solutions includes three primary platforms that will augment MethodHub's service delivery:

MethodHub will continue to provide comprehensive Pharmacovigilance services, including case processing, adverse event reporting, signal detection, aggregate reporting, audit readiness, and quality assurance. These services will now be augmented by Datafoundry's AI platforms, enabling seamless integration of data, automation, and analytics into PV operations.

Mr. Ahobilam, CEO and Executive Director of MethodHub Software Limited, emphasized that Pharmacovigilance has become central to patient safety and brand trust. He stated that the partnership brings together cutting-edge AI platforms, domain expertise, and scalable service delivery to help clients build future-ready, intelligent PV ecosystems. Additionally, MethodHub will utilize its proprietary AI-powered full-time hiring platform, QuantumHire, to support clients in scaling specialized Pharmacovigilance talent efficiently.

MethodHub serves 40+ global clients with a team of 500+ professionals across key international markets. The company maintains globally recognized certifications, including ISO 27001, ISO 9001, SOC 2 Type II, and HIPAA HITECH, positioning it as a trusted partner for mission-critical pharma operations.